GT Metabolic expands MagDI System with FDA clearance of 50mm magnet
The FDA has cleared GT Metabolic Solutions’ larger, 50mm MagDISystem magnet to complement the system's existing 40mm magnet. This...
top of page
Headlines
GT Metabolic expands MagDI System with FDA clearance of 50mm magnet
The FDA has cleared GT Metabolic Solutions’ larger, 50mm MagDISystem magnet to complement the system's existing 40mm magnet. This...
Research
First human implant of GLP-1 Implant NPM-115
Vivani Medical has announced the successful administration of its first GLP-1 (exenatide) implant in the LIBERATE-1 clinical trial,...
Roche and Zealand Pharma to co-develop and co-commercialise petrelintide for metabolic diseases
Roche and Zealand Pharma have entered into an exclusive collaboration and licensing agreement to co-develop and co-commercialise...
Small intestine APOA4 protein could hold key to obesity treatment
A team of Ohio University researchers have made a ground-breaking development in the fight against obesity. In a study recently published...
Extreme weight fluctuation increases risk of death for PLWO
New research has found for the first time that extreme weight fluctuations in people living with obesity (PLWO) and cardiovascular...
BMI three times more likely to classify children as overweight vs. waist circumference-to-height ratio
Body mass index (BMI) was almost three times more likely to classify children as overweight as a waist circumference-to-height ratio,...
Journal Watch 12/3/2025
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Ascletis reveals pharmacokinetic and weight loss data from its ASC47 Phase Ib single subcutaneous injection
Ascletis Pharma has announced pharmacokinetic and weight loss data from its ASC47 Phase Ib single subcutaneous injection studies in...
GT Metabolic expands MagDI System with FDA clearance of 50mm magnet
The FDA has cleared GT Metabolic Solutions’ larger, 50mm MagDISystem magnet to complement the system's existing 40mm magnet. This...
OMP reveals additional three-month data for its Sirona dual-polymer hydrogel pill
Oxford Medical Products (OMP) has announced the additional three-month clinical trial results for Sirona, a weight-loss treatment...
Genome-edited stem cells offer hope for obesity treatment without muscle loss
Researchers at the Beijing Institute of Stem Cells and Regeneration (BISCRM) and the Institute of Zoology (IOZ) have cracked the code of...
VIVUS launches QSYMIA in the UAE
VIVUS has received market approval of QSYMIA (phentermine and topiramate extended-release capsules) CIV in the United Arab Emirates (UAE)...
REDEFINE 2: CagriSema demonstrates superior weight loss
Outcomes from the from REDEFINE 2, a phase 3 trial in the global REDEFINE programme, have revealed the trial achieved its primary...
Industry
All caught up?
New: Directory
Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.
Events
Tweets
bottom of page